Literature DB >> 1382894

Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women.

H Alfthan1, C Haglund, J Dabek, U H Stenman.   

Abstract

Sensitive, specific time-resolved immunofluorometric assays were used to measure the concentrations of human choriogonadotropin (hCG), free beta-subunit (beta-hCG), and the core fragment of beta-hCG (c beta-hCG) in serum and urine of men and nonpregnant women without evidence of cancer. Concentrations of hCG and beta-hCG were measurable in 59-70% of serum samples and in 50-59% of urine samples. c beta-hCG was mostly undetectable in serum but measurable in 81% of urine samples. Concentrations were higher in women than in men, and hCG concentrations increased with age. Therefore, reference ranges based on the 97.5 percentile were calculated separately for women and men and for those < 50 and > 50 years. However, concentrations of hCG correlated much more strongly with those of follicle-stimulating hormone than with age. hCG concentrations in serum were similar to those reported before, but beta-hCG concentrations were below the detection limit of earlier assays, and the upper reference limit was one-fifth to one-tenth the cutoff concentrations used earlier. In urine, hCG and c beta-hCG were the major forms of hCG, and their concentrations were similar to those of hCG in serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382894

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

1.  A low-cost smartphone-based platform for highly sensitive point-of-care testing with persistent luminescent phosphors.

Authors:  Andrew S Paterson; Balakrishnan Raja; Vinay Mandadi; Blane Townsend; Miles Lee; Alex Buell; Binh Vu; Jakoah Brgoch; Richard C Willson
Journal:  Lab Chip       Date:  2017-03-14       Impact factor: 6.799

2.  Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.

Authors:  G Valdés; A M Germain; J Corthorn; C Berrios; A C Foradori; C M Ferrario; K B Brosnihan
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

3.  Pregnancy, malignancy or mother nature? Persistence of high hCG levels in a perimenopausal woman.

Authors:  Ayşe Y Demir; Ruben Ea Musson; Willem A Schöls; Jitze M Duk
Journal:  BMJ Case Rep       Date:  2019-01-03

4.  The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.

Authors:  Anni Sjöblom; Timo Carpén; Ulf-Håkan Stenman; Lauri Jouhi; Caj Haglund; Stina Syrjänen; Petri Mattila; Antti Mäkitie; Jaana Hagström
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

5.  The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.

Authors:  Akitoshi Takizawa; Koji Kawai; Takashi Kawahara; Takahiro Kojima; Satoru Maruyama; Nobuo Shinohara; Shusuke Akamatsu; Tomomi Kamba; Terukazu Nakamura; Osamu Ukimura; Ryosuke Jikuya; Takeshi Kishida; Kenichi Kakimoto; Kazuo Nishimura; Toru Harabayashi; Satoshi Nagamori; Shinichi Yamashita; Yoichi Arai; Yoshitomo Sawada; Noritoshi Sekido; Hidefumi Kinoshita; Tadashi Matsuda; Tohru Nakagawa; Yukio Homma; Hiroyuki Nishiyama
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-13       Impact factor: 4.553

6.  Analytical and clinical validation of the Immulite 1000 hCG assay for quantitative analysis in urine.

Authors:  Frances L Cate; Courtney Moffett; Ann M Gronowski; David G Grenache; Katherine E Hartmann; Alison Woodworth
Journal:  Clin Chim Acta       Date:  2013-03-05       Impact factor: 3.786

Review 7.  Sample preparation: the weak link in microfluidics-based biodetection.

Authors:  Raymond Mariella
Journal:  Biomed Microdevices       Date:  2008-12       Impact factor: 2.838

Review 8.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

9.  Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.

Authors:  Getachew A Woldemariam; Anthony W Butch
Journal:  Clin Chem       Date:  2014-06-04       Impact factor: 8.327

10.  Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.

Authors:  Miriam Lenhard; Alexandra Tsvilina; Lan Schumacher; Markus Kupka; Nina Ditsch; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.